ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 763635 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 763635; 2) Community: the network communities that were significantly associated with the response to NSC 763635; 3) Molecule: the relationships between components within communities and NSC 763635; 4) MDR: the compounds that were significantly associated with the NSC 763635.

NSC Compound Enrichment Correlation
NSC 363979 Cephalostatin 1 0.000141616984257996 0.35728194
NSC 648365 Insulin-Methotrexate conjugate 0.000174252554411806 0.31550407
NSC 67588 2-Naphthacenecarboxamide, 4-dimethylamino-1,4,4a,5,5a,6,11,12a-pentahydroxy-N-[6-mercaptopurin-7(or 9)-ylmethyl]-6-methyl-1,11-dioxo- 0.000337797539144495 -0.058497072
NSC 671043 2-Ethoxyestra-1,3,5-trien-3,17.beta.-diol 0.000463656464354233 0.33401169
NSC 666112 Null 0.000572036815736153 0.09182778
NSC 706044 Null 0.000574000735425498 0.2567304
NSC 670421 Null 0.000613655894404025 0.082100576
NSC 686425 Null 0.000982682177273506 0.32369836
NSC 92585 Benzoic acid, p-[(purin-6-ylthio)mercuri]- 0.00098268217727352 0.18143553
NSC 735211 CSA13 0.00131875202369342 0.31762851
Total:49  Current:1    [First] [Prev] [Next] [Last]